Our Company

CellSure is a birth tissue stem cell storage and donation company, based in Utah. We aspire to make birth tissue stem cell storage accessible to every family. We use our experience and expertise to aid in pioneering next-generation medical innovations in life-changing stem cell therapies.

We are a low-profit limited liability company—or L3C—which is a special designation for companies that place a higher priority on achieving a social mission than on making profits. This provides you the confidence to know we put the wellbeing of people before profit. We treat each interaction as an opportunity to demonstrate this commitment. We treat each donation as a priceless gift of love and hope. We treat each storage with the care and expertise as if it were our own.


Enrich lives


To empower expectant mothers to make an informed decision about their baby’s birth tissue stem cells.


Give birth to your precious baby. Give hope to someone in need. #GiveBirthGiveHope


Every day, billions of valuable birth tissue stem cells are discarded as medical waste. We offer expectant mothers the options to store or donate their baby’s birth tissue. Parents can have peace of mind knowing that their baby’s stem cells are either available to them of needed, or that their baby’s stem cells are a priceless gift of hope so others can live longer healthier lives.

Contact Info

650 Komas Drive, Suite 107
Salt Lake City, UT 84108


Founder, President and CEO
Chief Medical Officer

Corporate Headquarters Salt Lake City, UT
Year Established 2017
Structure Low-profit Limited Liability (L3C)
Ownership Subsidiary of Predictive Biotech
Industry Birth Tissue Procurement Organization

Key Differentiators

Collection kit contains an active cooling system, not just insulation.
Offer storage and donation services direct to parents across the US.
Only company that offers whole placenta banking as an alternative to cord blood banking.
Subsidiary of Predictive Biotech
Only company in the U.S. that has fully integrated personal and public banking of newborn stem cells.